Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > OR Providers

Dr. Jeffrey Irving Menashe, MD

(No ratings)

Specializes in: Adult Oncology and Adult Hematology

5050 Ne Hoyt Street Suite 256
Portland, OR 97213

(503) 239-7767

Dr. Jeffrey Irving Menashe, MD is an oncologist in Portland, OR specializing in adult oncology and adult hematology. Dr. Jeffrey Irving Menashe, MD is affiliated with Legacy Good Samaritan Medical Center and Legacy Health.

Office Locations

Address:

5050 Ne Hoyt Street Suite 256
Portland, OR 97213

biological response modifier (BRM) therapy	147
blood draw	594
chemotherapy	147
doctor visit	636
hospital care	84
inpatient care	84
lab tests	2020
minimally invasive procedures	174

**Gender**
Male	135
Female	162

**Ethnicity**
Non-Hispanic White	259
Black	15
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	137
From 75 to 84	80
85 and over	44
Less than 65	36

Hypertension	54
High Cholesterol	35
Stroke	0
Ischemic Heart Disease	24
Depression	17
Chronic Kidney Disease	33
Asthma	6
Osteoperosis	7
Atrial Fibrilation	10
Heart Failure	20
Chronic Obstructive Pulmonary Disease	10
Diabetes	26
Dementia	9
Cancer	34

**Ethnicity**
Non-Hispanic White	253
Black	12
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	117
From 75 to 84	87
85 and over	41
Less than 65	39

Hypertension	51
High Cholesterol	37
Stroke	0
Ischemic Heart Disease	27
Depression	21
Chronic Kidney Disease	32
Asthma	6
Osteoperosis	9
Atrial Fibrilation	11
Heart Failure	18
Chronic Obstructive Pulmonary Disease	9
Diabetes	24
Dementia	7
Cancer	35

biological response modifier (BRM) therapy	82
blood draw	628
chemotherapy	82
doctor visit	612
lab tests	2180
minimally invasive procedures	160

**Gender**
Male	236
Female	338

**Ethnicity**
Non-Hispanic White	516
Black	26
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	238
From 75 to 84	196
85 and over	56
Less than 65	84

Hypertension	51
High Cholesterol	36
Stroke	7
Ischemic Heart Disease	21
Depression	21
Chronic Kidney Disease	32
Asthma	10
Osteoperosis	7
Atrial Fibrilation	9
Heart Failure	16
Chronic Obstructive Pulmonary Disease	11
Diabetes	24
Dementia	5
Cancer	34

biological response modifier (BRM) therapy	125
blood draw	591
chemotherapy	125
doctor visit	597
hospital care	26
inpatient care	26
lab tests	1975
minimally invasive procedures	193
port flush	19

**Gender**
Male	115
Female	183

**Ethnicity**
Non-Hispanic White	268
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	141
From 75 to 84	82
85 and over	37
Less than 65	38

Hypertension	54
High Cholesterol	36
Stroke	0
Ischemic Heart Disease	23
Depression	19
Chronic Kidney Disease	37
Asthma	15
Osteoperosis	10
Atrial Fibrilation	13
Heart Failure	19
Chronic Obstructive Pulmonary Disease	12
Diabetes	27
Dementia	8
Cancer	35

biological response modifier (BRM) therapy	127
blood draw	693
chemotherapy	127
doctor visit	654
lab tests	2464
minimally invasive procedures	169
port flush	20
thyroid function tests	43

**Gender**
Male	145
Female	191

**Ethnicity**
Non-Hispanic White	291
Black	15
Hispanic	0
Asian	0
Other	14
Native American	0

**Age**
From 65 to 74	167
From 75 to 84	93
85 and over	39
Less than 65	37

Hypertension	56
High Cholesterol	35
Stroke	5
Ischemic Heart Disease	24
Depression	22
Chronic Kidney Disease	34
Asthma	9
Osteoperosis	9
Atrial Fibrilation	14
Heart Failure	18
Chronic Obstructive Pulmonary Disease	14
Diabetes	27
Dementia	5
Cancer	34

biological response modifier (BRM) therapy	150
blood draw	839
chemotherapy	150
doctor visit	719
hormone therapy	18
hospital care	35
inpatient care	35
lab tests	2949
minimally invasive procedures	207
port flush	40
thyroid function tests	85

**Gender**
Male	147
Female	202

**Ethnicity**
Non-Hispanic White	305
Black	16
Hispanic	0
Asian	0
Other	13
Native American	0

**Age**
From 65 to 74	167
From 75 to 84	108
85 and over	35
Less than 65	39

Hypertension	58
High Cholesterol	40
Stroke	4
Ischemic Heart Disease	21
Depression	22
Chronic Kidney Disease	35
Asthma	7
Osteoperosis	11
Atrial Fibrilation	11
Heart Failure	19
Chronic Obstructive Pulmonary Disease	12
Diabetes	25
Dementia	7
Cancer	35

biological response modifier (BRM) therapy	132
blood draw	850
chemotherapy	132
doctor visit	733
hormone therapy	24
hospital care	109
inpatient care	109
lab tests	3000
minimally invasive procedures	209
port flush	19
thyroid function tests	62

**Gender**
Male	145
Female	191

**Ethnicity**
Non-Hispanic White	297
Black	12
Hispanic	0
Asian	0
Other	15
Native American	0

**Age**
From 65 to 74	163
From 75 to 84	106
85 and over	31
Less than 65	36

Hypertension	0
High Cholesterol	42
Stroke	4
Ischemic Heart Disease	22
Depression	26
Chronic Kidney Disease	37
Asthma	7
Osteoperosis	10
Atrial Fibrilation	10
Heart Failure	19
Chronic Obstructive Pulmonary Disease	12
Diabetes	26
Dementia	6
Cancer	31

biological response modifier (BRM) therapy	94
blood draw	710
chemotherapy	94
doctor visit	639
hormone therapy	25
hospital care	141
inpatient care	141
lab tests	2613
minimally invasive procedures	163
thyroid function tests	33

**Gender**
Male	139
Female	174

**Ethnicity**
Non-Hispanic White	267
Black	0
Hispanic	0
Asian	0
Other	17
Native American	0

**Age**
From 65 to 74	158
From 75 to 84	89
85 and over	31
Less than 65	35

Hypertension	55
High Cholesterol	40
Stroke	4
Ischemic Heart Disease	22
Depression	23
Chronic Kidney Disease	37
Asthma	7
Osteoperosis	12
Atrial Fibrilation	10
Heart Failure	19
Chronic Obstructive Pulmonary Disease	8
Diabetes	29
Dementia	6
Cancer	34

biological response modifier (BRM) therapy	222
blood draw	1195
chemotherapy	222
doctor visit	1129
hospital care	40
inpatient care	40
lab tests	4637
minimally invasive procedures	335
thyroid function tests	78

Average Medicare Procedure Volume From 2013 - 2021

Volume of procedures performed by Dr. Jeffrey Irving Menashe, MD for Medicare patients.

The highest averages for the top procedures that Dr. Jeffrey Irving Menashe, MD treated as an oncologist in Portland, OR were lab tests, blood draw, minimally invasive procedures and chemotherapy.

aspiration	11
biological response modifier (BRM) therapy	136
blood draw	743
bone marrow tests	22
chemotherapy	136
diagnostic procedures	22
doctor visit	705
hormone therapy	22
hospital care	69
inpatient care	69
lab tests	2664
minimally invasive procedures	197
thyroid function tests	60

Average Medicare Patient Data From 2013 - 2021

Information about Medicare patients treated by Dr. Jeffrey Irving Menashe, MD.

**Gender**
Male	118
Female	160

**Ethnicity**
Black / African American	9
Asian / Pacific Islander	0
Non-Hispanic White	245
Native American / Alaskan Native	0
Hispanic	0
Other	5

**Age**
85 and over	31
75 to 84	84
Less than 65	34
65 to 74	128

Average of Total of Conditions of Medicare patients treated by Dr. Jeffrey Irving Menashe, MD From 2013 - 2021

The highest averages of the most common conditions of Medicare patients that Dr. Jeffrey Irving Menashe, MD treated were hypertension, high cholesterol, chronic kidney disease and cancer.

Hypertension	37
High Cholesterol	30
Stroke	2
Ischemic Heart Disease	18
Depression	17
Chronic Kidney Disease	27
Asthma	6
Osteoporosis	7
Heart Failure	14
Chronic Obstructive Pulmonary Disease	8
Diabetes	20
Atrial Fibrillation	8
Dementia	5
Cancer	27

Education & Training

He is certified by the Oncology, Board-certified and has a state license in Oregon.

Board Certification: Oncology, Board-certified

Licensed In: Oregon

Affiliations & Hospitals

Dr. Jeffrey Irving Menashe, MD is associated with these hospitals and organizations:

Legacy Good Samaritan Medical Center

Legacy Health

Ratings & Reviews

Dr. Jeffrey Irving Menashe, MD does not have any reviews yet, be the first to leave a review of Dr. Jeffrey Irving Menashe, MD here: Leave a Review

(No ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Jeffrey Irving Menashe, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Celgene Corporation	$48,001 Revlimid $34,597	Reblozyl $2,092	ONUREG $1,730	Pomalyst $1,000	$8,581
Millennium Pharmaceuticals, Inc.	$21,126 NINLARO $21,126
E.R. Squibb & Sons, L.L.C.	$14,115 ONUREG $7,666	Reblozyl $4,216	Pomalyst $1,979	OPDIVO $146	EMPLICITI $103	Other $5
AbbVie, Inc.	$13,625 Venclexta $13,625
Daiichi Sankyo Inc.	$4,595 $4,595
Other	$15,337 Zydelig $3,528	SGN35 $2,455	XPOVIO $2,325	None $1,800	SOLIRIS $1,604	Other $3,625

**Types of Payments**
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	$50,865
Consulting Fee	$42,562
Travel and Lodging	$15,754
Honoraria	$4,325
Food and Beverage	$3,218
Other	$73

Research Payments

Dr. Jeffrey Irving Menashe, MD has received 5 research payments totaling $212,913.

Biography

Dr. Jeffrey Menashe is an adult hematology and adult oncology specialist in Portland, OR. He offers interpreting services for his patients. He is affiliated with Legacy Good Samaritan Medical Center.